Z

Zosano Pharma Corp
F:0ZPN

Watchlist Manager
Zosano Pharma Corp
F:0ZPN
Watchlist
Price: 0.525 EUR Market Closed
Market Cap: €18.9m

Net Margin

-9 832%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-9 832%
=
Net Income
$-55.2m
/
Revenue
$660k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-9 832%
=
Net Income
€-55.2m
/
Revenue
$660k

Peer Comparison

Country Company Market Cap Net
Margin
US
Zosano Pharma Corp
F:0ZPN
18.9m EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.3B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Lower than 96% of companies in the United States of America
Percentile
4th
Based on 15 072 companies
4th percentile
-9 832%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Zosano Pharma Corp
Glance View

Market Cap
18.9m EUR
Industry
Health Care

Zosano Pharma Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Fremont, California and currently employs 40 full-time employees. The company went IPO on 2015-01-27. Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The firm is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using its transdermal microneedle system (the System). Its System is designed to facilitate rapid drug absorption into the bloodstream, and to provide an improved pharmacokinetic (PK) profile compared to original dosage forms. The System consists of a three cm square to six cm square array of titanium microneedles approximately 200-350 microns in length, coated with a hydrophilic formulation of drug, mounted on an adhesive patch. The company is focused on development of its lead product candidate, M207, a formulation of zolmitriptan, which is used as an acute treatment for migraine. Its zolmitriptan formulation is delivered utilizing its system. M207 is designed to provide rapid absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal (GI) tract.

0ZPN Intrinsic Value
Not Available
Z
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-9 832%
=
Net Income
$-55.2m
/
Revenue
$660k
How has Net Margin changed over time?

Over the last 1 years, Zosano Pharma Corp’s Net Margin has increased from -18 537.2% to -9 832%. During this period, it reached a low of -18 537.2% on Dec 31, 2020 and a high of -3 909.9% on Sep 30, 2021.

Back to Top